IYH
iShares U.S. Healthcare ETF
iShares U.S. Healthcare ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Dow Jones U.S. Healthcare Sector Index.
US
EQUITY
Passive
MANAGEMENT STYLE
$ 2.9 B
ASSETS UNDER MGMT
40 bp
EXPENSES
Fund Basics
| Inception date | Jun 12, 2000 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ELI LILLY & CO | 13.7 % |
| JOHNSON & JOHNSON | 10.4 % |
| ABBVIE INC | 6.7 % |
| MERCK & CO. INC. | 5.5 % |
| UNITEDHEALTH GROUP INC | 5.0 % |
| AMGEN INC | 3.4 % |
| THERMO FISHER SCIENTIFIC INC | 3.4 % |
| ABBOTT LABORATORIES | 3.2 % |
| GILEAD SCIENCES INC | 3.2 % |
| INTUITIVE SURGICAL INC | 2.9 % |
Constituent Breakdown
| Number of holdings | 103 |
| Herfindahl-Hirschman Index | 499 |
| Wgt avg mkt cap (mns) | $305,396 |
| Large cap (>$10bn) | 97.5% |
| Mid cap ($2-10bn) | 2.1% |
| Small cap (<$2bn) | 0.1% |
| Developed mkts. | 99.7% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 96.8 % |
 |
IRELAND | 2.7 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -5.3% | 1.2% | -0.2% | 4.1% | 4.1% | 8.2% | 8.2% | 6.3% |
| Dividend Yield | 0.3% | 1.3% | 1.2% | 1.3% | 1.2% | 1.4% | 1.5% | 1.3% |
| Total Returns | -5.0% | 2.6% | 1.0% | 5.4% | 5.3% | 9.6% | 9.7% | 7.7% | Ann. Volatility | 15.2% | 18.0% | 15.2% | 13.9% | 14.8% | 16.7% | 17.0% | 17.5% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.57 | 36% |
| MSCI EAFE | 0.64 | 40% |
| MSCI Emg Mkts | 0.43 | 23% |
Liquidity Measures
| Avg. volume (000) | 647 |
| ADV traded (mns) | $40 |
| Turnover | 1.4% |
| Avg. Bid/Ask (% of price) | 0.02% |
Technical Indicators
| 30d moving avg. (EMA) | $62.41 |
| Relative strength (RSI) | 48 |
| MACD/Signal | -0.19/-0.40 |
| Bollinger Bands (Upper/Lower) | $63.20/$60.00 |
| Short interest (% of AUM) | 1.7% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. IYH |
Expenses vs. IYH |
ALTAR Score™ vs. IYH |
|---|---|---|---|---|
| XLV | Health Care Select Sector SPDR | 91.4% | -32 bp | +0.8% |
| FHLC | Fidelity MSCI Health Care Index ETF | 85.8% | -32 bp | -0.6% |
| VHT | Vanguard Health Care ETF | 82.8% | -31 bp | -0.8% |
| IXJ | iShares Global Healthcare ETF | 65.3% | +2 bp | +0.4% |
| HRTS | Tema Heart & Health ETF | 54.2% | +35 bp | -3.2% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 47.8% | +20 bp | +1.1% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 47.2% | 0 bp | +0.6% |
| MEDX | Horizon Kinetics Medical ETF | 42.1% | +45 bp | -4.9% |
| PJP | Invesco Pharmaceuticals ETF | 38.4% | +17 bp | +1.6% |
| FXH | First Trust Health Care AlphaDEX Fund | 38.1% | +22 bp | -0.9% |
Risk and Returns: IYH vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/21/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.4%
ALTAR SCORE™
68th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,201 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. IYH's ALTAR Score™ is approximately 0.5 standard
deviations above the category average. This places IYH in the 68th percentile
among funds in the category.
Sell-Side Consensus
$75.57
PRICE TARGET
+21.7%
UPSIDE